EGFR and head and neck squamous cell carcinoma: EGFR inhibition using gefitinib in combination with cisplatin, has been shown to enhance the pro-apoptotic and anti-proliferative effects of chemotherapy in vitro in selected (non-EGFR amplified) HNSCC commercially available cell lines (37).